ChemicalBook >> CAS DataBase List >>DS18561882

DS18561882

CAS No.
2227149-22-4
Chemical Name:
DS18561882
Synonyms
DS18561882;DS18561882,DS-18561882;(S)-N-(4-(8-(3,4-Dimethylpiperazin-1-yl)-7-methyl-5-oxo-1,3,4,5-tetrahydro-2H-chromeno[3,4-c]pyridine-3-carbonyl)-2-(trifluoromethoxy)phenyl)methanesulfonamide;Methanesulfonamide, N-[4-[[8-[(3S)-3,4-dimethyl-1-piperazinyl]-1,5-dihydro-7-methyl-5-oxo-2H-[1]benzopyrano[3,4-c]pyridin-3(4H)-yl]carbonyl]-2-(trifluoromethoxy)phenyl]-
CBNumber:
CB95848750
Molecular Formula:
C28H31F3N4O6S
Molecular Weight:
608.63
MDL Number:
MFCD32263053
MOL File:
2227149-22-4.mol
Last updated:2025-10-13 16:10:46

DS18561882 Properties

Boiling point 754.3±70.0 °C(Predicted)
Density 1.47±0.1 g/cm3(Predicted)
storage temp. Store at -20°C
solubility DMSO: 250 mg/mL (410.76 mM)
form Solid
pka 6.61±0.10(Predicted)
color White to yellow

DS18561882 Chemical Properties,Uses,Production

Description

DS18561882 is an isozyme-selective MTHFD2 inhibitor. DS18561882 shows a good oral pharmacokinetic profile, and thereby tumor growth inhibition in a mouse xenograft model upon oral administration.

Uses

DS18561882 is a highly potent, isozyme-selective methylenetetrahydrofolate dehydrogenase 2 (MTHFD2) inhibitor with an IC50 value of 0.0063 μM. DS18561882 also has inhibitory effect on MTHFD1 (IC50=0.57 μM). DS18561882 exhibits a good oral pharmacokinetic profile[1].

in vivo

DS18561882 (oral administration; 30, 100 or 300 mg/kg; twice daily) inhibits tumor growth inhibition with a dose-dependent manner, the tumor is completely inhibited (TGI: 67%) at the dose of 300 mg/kg in mice[1]. DS18561882 (oral administration; 10, 30, 100, or 300 mg/kg) has a good oral pharmacokinetic profile, including ACU (64.6, 264, 726 μg.h/ml ); Cmax (11.4, 56.5, 90.1 μg/ml); t1/2 (2.21, 2.16, 2.32 hours) for 30 mg/kg; 100mg/kg; 200 mg/kg, respectively[1]. DS18561882 is suspended in a 0.5% (w/v) methyl cellulose 400 solution in this article[1].

Animal Model:Five week old female BALB/cAJcl-nu/nu mice with MDA-MB-231 luc tumor cells (4 × 106 cells/mouse)[1]
Dosage:30, 100 or 300 mg/kg
Administration:Oral administration; 30, 100 or 300 mg/kg; twice daily; until day 11
Result:Suppressed tumor growth in a dose-dependent manner.

References

[1] Kawai J, et al. Discovery of a Potent, Selective, and Orally Available MTHFD2 Inhibitor (DS18561882) with In Vivo Anti-Tumor Activity. J Med Chem. 2019 Oct 22. DOI:10.1021/acs.jmedchem.9b01113

DS18561882 Preparation Products And Raw materials

Raw materials

Preparation Products

DS18561882 Suppliers

Global( 24)Suppliers
Supplier Tel Email Country ProdList Advantage
TargetMol Chemicals Inc.
+1-781-999-5354; +17819995354 marketing@targetmol.com United States 32434 58
TargetMol Chemicals Inc.
+1-781-999-5354; support@targetmol.com United States 39031 58
Aladdin Scientific
tp@aladdinsci.com United States 52924 58
Shanghai Hanhong Scientific Co., Ltd.
+undefined17612118332 Lucky@hanhonggroup.com China 5844 58
Shanghai EFE Biological Technology Co., Ltd. 021-65675885 18964387627 info@efebio.com China 9803 58
Shanghai Chaolan Chemical Technology Center 021-QQ:65489617 15618227136 Sales@ATKchemical.com China 9954 58
Suzhou Rovathin Foreign Trade Co.,Ltd 0512-65816829 18662214788 info@rovathin.com.cn China 9938 58
Shanghai Dongyang Biotechnology Co., Ltd. 0512-0512-13601744364 13601744364 chemsharker@126.com China 999 58
ChemeGen(Shanghai) Biotechnology Co.,Ltd. 18818260767 sales@chemegen.com China 11218 58
Shanghai hongqu biomedical technology co. LTD 88888888888 hongquchem@qq.com China 5132 58

View Lastest Price from DS18561882 manufacturers

Image Update time Product Price Min. Order Purity Supply Ability Manufacturer
DS18561882 pictures 2025-10-13 DS18561882
2227149-22-4
US $117.00-455.00 / mg 99.25% 10g TargetMol Chemicals Inc.
DS18561882 pictures 2025-10-13 DS18561882
2227149-22-4
US $117.00-455.00 / mg 99.25% 10g TargetMol Chemicals Inc.
  • DS18561882 pictures
  • DS18561882
    2227149-22-4
  • US $117.00-455.00 / mg
  • 99.25%
  • TargetMol Chemicals Inc.
  • DS18561882 pictures
  • DS18561882
    2227149-22-4
  • US $117.00-455.00 / mg
  • 99.25%
  • TargetMol Chemicals Inc.
DS18561882 Methanesulfonamide, N-[4-[[8-[(3S)-3,4-dimethyl-1-piperazinyl]-1,5-dihydro-7-methyl-5-oxo-2H-[1]benzopyrano[3,4-c]pyridin-3(4H)-yl]carbonyl]-2-(trifluoromethoxy)phenyl]- DS18561882,DS-18561882 (S)-N-(4-(8-(3,4-Dimethylpiperazin-1-yl)-7-methyl-5-oxo-1,3,4,5-tetrahydro-2H-chromeno[3,4-c]pyridine-3-carbonyl)-2-(trifluoromethoxy)phenyl)methanesulfonamide 2227149-22-4 C28H31F3N4O6S